VOR: Vor Biopharma Inc. Stock

by  •  • Comments Off on VOR: Vor Biopharma Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 87.40
Enterprise Value ($M) 5.45
Book Value ($M) 96.66
Book Value / Share 0.77
Price / Book 0.90
NCAV ($M) 50.28
NCAV / Share 0.40
Price / NCAV 1.74

Profitability (mra)
Return on Invested Capital (ROIC) -0.91
Return on Assets (ROA) -0.70
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 5.19
Current Ratio 5.19

Balance Sheet (mrq) ($M)
Current Assets 96.51
Assets 142.89
Liabilities 46.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -121.19
Net Income -116.91

Cash Flow Statement (mra) ($M)
Cash From Operations -99.66
Cash from Investing 96.86
Cash from Financing 53.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 9.30 -15.74
01-07 13D Reprogrammed Interchange LLC 31.30
12-30 13D/A Ra Capital Management, L.p. 31.90 74.32
11-14 13G/A Paradigm Biocapital Advisors LP 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-14 68,623 209,846 32.70
2025-04-11 47,423 167,451 28.32
2025-04-10 71,313 200,577 35.55
2025-04-09 94,156 367,622 25.61

(click for more detail)

Similar Companies
VERV – Verve Therapeutics, Inc. VIGL – Vigil Neuroscience, Inc.
VIR – Vir Biotechnology, Inc. VRTX – Vertex Pharmaceuticals Incorporated
VTRS – Viatris Inc.


Financial data and stock pages provided by
Fintel.io